Shandong Ruifeng Chemical (300243.SZ) has been reviewed as a champion enterprise in the manufacturing industry.
Ruifeng Gao Cai (300243.SZ) announced that the Ministry of Industry and Information Technology recently issued the "Notice of the Ministry of Industry and Information Technology on the Issuance of the Ninth Batch of Manufacturing Single Champion Enterprises and the Re-examination of the Third Batch and Sixth Batch of Manufacturing Single Champion Enterprises" (MIIT ZhengFa Letter [2025] No. 332). According to the list of enterprises, the company has passed the re-examination of the third batch of manufacturing single champion enterprises.
Shandong Ruifeng Chemical (300243.SZ) announced that the Ministry of Industry and Information Technology recently issued a notice on the approval of the third batch of manufacturing single champion enterprises for reexamination, as well as the list of manufacturing single champion enterprises approved in the third and sixth batches. According to the list of enterprises, the company has been approved in the reexamination of the third batch of manufacturing single champion enterprises.
Related Articles
HK Stock Market Move | KANGQIAO SER (02205) soared more than 80% in the afternoon, and the company signed a cooperation memorandum with Askitect to jointly promote the implementation of AI technology in all scenarios.
HK Stock Market Move | IMMUNEONCO-B(01541) rose nearly 4%. The self-developed subcutaneous formulation IMM0306S of Amuviraprop has received clinical trial approval.
New Stock News | TianSu ZhiXin passed the hearing of the Hong Kong Stock Exchange, and the shipment volume of general GPU products continues to climb.
HK Stock Market Move | KANGQIAO SER (02205) soared more than 80% in the afternoon, and the company signed a cooperation memorandum with Askitect to jointly promote the implementation of AI technology in all scenarios.
HK Stock Market Move | IMMUNEONCO-B(01541) rose nearly 4%. The self-developed subcutaneous formulation IMM0306S of Amuviraprop has received clinical trial approval.
New Stock News | TianSu ZhiXin passed the hearing of the Hong Kong Stock Exchange, and the shipment volume of general GPU products continues to climb.
